Abstract: Metabolic sugar labeling followed by the use of reagent-free click chemistry is an established technique for in vitro cell targeting.However,selective metabolic labeling of the target tissues in vivo remains ac hallenge to overcome, which has prohibited the use of this techniquef or targeted in vivo applications.H erein, we report the use of targeted ultrasound pulses to induce the release of tetraacetyl Nazidoacetylmannosamine (Ac 4 ManAz) from microbubbles (MBs) and its metabolic expression in the cancer area. Ac 4 ManAz-loaded MBs showed great stability under physiological conditions,b ut rapidly collapsed in the presence of tumor-localized ultrasound pulses.T he released Ac 4 ManAz from MBs was able to label 4T1 tumor cells with azido groups and significantly improved the tumor accumulation of dibenzocyclooctyne (DBCO)-Cy5 by subsequent clickc hemistry. We demonstrated for the first time that Ac 4 ManAz-loaded MBs coupled with the use of targeted ultrasound could be asimple but powerful tool for in vivo cancer-selective labeling and targeted cancer therapies.
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Asanefficient method of incorporating chemical groups into cell-surface glycoproteins,metabolic labeling of unnatural sugars has been widely used for glycan visualization, glycoproteomics,a nd cell labeling. [1] [2] [3] Recently,r esearchers have shown increasing interest in applying it to cancer targeting by coupling with bioorthogonal chemistries. [4] [5] [6] In the first step,unnatural sugars with reactive chemical groups (such as azides) are delivered and metabolized in the cancerous tissues,f ollowed by the targeted delivery of dibenzocyclooctyne (DBCO)-bearing therapeutics by the click chemistry in the second step.D espite being at wo-step process,t his strategy has several advantages in cancer targeting:1 )excellent targeting can be achieved by taking advantage of the rapid, highly efficient click chemistry; 2) receptor saturation and immunogenicity problems in conventional protein-based targeting strategies can be avoided by using manually installed chemical receptors; [7] [8] [9] and 3) smallmolecule DBCO as targeting ligands can be easily incorporated into therapeutic agents or nanomedicines with tunable density.One key challenge in using this two-step strategy for in vivo cancer targeting is to specifically deliver the azido sugars to the cancerous tissues.K im et al. [6] used chitosan nanoparticles to deliver azido sugars to cancers by taking advantage of the enhanced permeability and retention (EPR) effect of nanoparticles,b ut the targeting efficiency was very low with limited selectivity.
Ultrasound (US) imaging is widely used and recognized as as afe medical tool for disease diagnosis and treatment. [10] [11] [12] [13] Microbubbles (MBs) that entrap gas in ab iocompatible material to form micron-sized particles have achieved great success as US contrast agents (UCAs) owing to their high US reflectivity and great stability. [14] It is well established that high-amplitude US pressures cause expansion and contraction of MBs,r esulting in their disruption. [15] [16] [17] As econdary effect of MB destruction is the temporary increase of capillary permeability and production of transient poration in cell membranes. [18] [19] [20] [21] Researchers have reported the use of US pulses to burst MB-liposome conjugates and release the encapsulated drugs or genes specifically in the target tissues. [22] [23] [24] [25] We envision that cancer-localized US pulses with accurate tissue targeting capability can potentially be used to induce the release of azido sugars from MBs specifically in the cancerous tissues. [26] [27] [28] Herein, we report the design of tetraacetyl N-azidoacetylmannosamine (Ac 4 ManAz)-loaded MBs (Ac 4 -MBs) for effective in vivo cancer-selective labeling (Scheme 1). In the presence of high-amplitude US pressures localized in the cancerous tissues,t he MBs collapsed and released azido-sugar-loaded liposomes,a nd the temporarily increased capillary and cellular permeability facilitated the tumor penetration and cellular uptake of the released liposomes. [29] [30] [31] We next studied whether Ac 4 -MB was able to metabolically label 4T1 breast cancer cells with azido groups when exposed to an US pressure field. 4T1 cells in Ac 4 -MB containing medium were treated with US for 1min, further incubated for 3days,a nd then treated with DBCO-Cy5 for 1hto detect the expression of azido groups.The cells without US treatment were used as acontrol. As shown in Figure 1e , minimal Cy5 fluorescence intensity (FI) was observed on the surface of 4T1 cells in the absence of US treatment, indicating the great stability and minimal premature sugar release of MBs during incubation. Because of its relatively large size, Ac 4 -MB was unable to enter the 4T1 cells,and thus failed to release Ac 4 ManAz in cells for metabolic labeling.Incomparison, 4T1 cells exposed to high-amplitude US pressures showed strong Cy5 FI on the cell surface,s uggesting that Ac 4 -lipo were successfully released from the MBs,e ntered 4T1 cells through endocytosis, and released Ac 4 ManAz for subsequent metabolic labeling of cells.Presumably,liposomes released the encapsulated azido sugars through fusion with cellular or intracellular membranes or by lytic degradation in the lysosomes. [32] [33] [34] [35] We also tested the in vitro labeling kinetics of Ac 4 -lipo by incubating it with 4T1 cells for different times,a nd subsequently detecting the cell-surface azido groups using DBCO-Cy5. As ar esult, Ac 4 -lipo-mediated labeling of 4T1 cells was time-dependent, with the cell-surface azido density approaching aplataeu value after 72-96 h( Figure S5 ).
After demonstrating in vitro that Ac 4 -MB was able to metabolically label 4T1 breast cancer cells with azido groups only in the presence of US,w et hen went on to study whether targeted US pulses in the tumor area could be used to induce selective sugar labeling of tumor cells.A sap roof-of-concept study,w ef irst investigated whether targeted US in the tumor area could break intratumorally injected Ac 4 -MB and induce metabolic labeling of tumor cells.A c 4 -MB was injected directly into the subcutaneous 4T1 tumors on the flanks of BALB/c mice with simultaneous treatment of targeted US.T he right tumors were treated with highamplitude US pressure pulses (the US system output was set to the 100 %t ocollapse the MBs), while the left tumors were treated with low-amplitude US pressure pulses (the US system output was 4%,s ot hat the MBs would not collapse and yet still provide US imaging capability;F igure S7a, S7b). (Figure 4d ). In addition, the vast majority of Cy5-MB accumulated in liver and lung,showing an extremely low tumor-to-organ accumulation ratio ( Figure S10 ). These experiments validated that Ac 4 -MB coupled with DBCOcargo can not only mediate am uch higher cancer-targeting efficiency than cargo-loaded MB,but also enables the choice of cargo-delivery systems with more favorable pharmacokinetics than MB.Inanother set of experiments,wei.v.injected Ac 4 -MB into BALB/c mice once daily for three days with simultaneous US treatment on the right thigh muscles,a nd then i.v.injected DBCO-Cy5. At 48 hp .i. of DBCO-Cy5, the right thigh muscles with US treatment failed to show an increase of DBCO-Cy5 accumulation compared to the left thigh muscles without US treatment ( Figure S11 ), which together with the achieved 1.65-fold tumor-targeting effect (Figure 4d) , suggested that sugar expression in cancerous tissues was more favored than in normal tissues.
In summary,w ed eveloped Ac 4 -MB for cancer-targeted labeling and imaging with the assistance of targeted US. Targeted US pulses could induce the collapse of Ac 4 -MB (while being visualized under US imaging) and the release and metabolic expression of azido sugars within the tumor, which significantly increased the tumor accumulation of DBCO-Cy5 by 65 %t hrough the click reaction compared to the group without US treatment. More importantly,t he accumulation of DBCO-Cy5 in healthy tissues showed negligible changes.Incontrast to antibody-drug conjugate [36] and nanoparticle-ligand conjugate [37] [38] [39] [40] targeting strategies, which improve the cellular uptake instead of the overall tumor-organ accumulation ratio of drugs or drug delivery systems,o ur strategy can intrinsically enhance the tumororgan accumulation ratio of therapeutic agents.A c 4 -MB coupled with the use of targeted US could be as imple but powerful tool for in vivo cancer targeting and targeted cancer therapies. 
